TickerFactsScreenerDevelopers

REGENXBIO Inc. (RGNX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2015: $522.0K2016: $8.15M2017: $7.16M2018: $13.28M2019: $11.72M2020: $26.87M2021: $84.17M2022: $30.72M2023: $9.96M2024: $2.44M2025: $2.41M$2.41M
2015Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$2.41M-0.9%
2024$2.44M-75.5%
2023$9.96M-67.6%
2022$30.72M-63.5%
2021$84.17M+213.3%
2020$26.87M+129.3%
2019$11.72M-11.7%
2018$13.28M+85.4%
2017$7.16M-12.1%
2016$8.15M+1461.1%
2015$522.0K—